The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers

被引:79
|
作者
Weers, Jeffry [1 ]
Clark, Andy [2 ]
机构
[1] Novartis Pharmaceut, 150 Ind Rd, San Carlos, CA 94070 USA
[2] Aerogen Pharma, San Mateo, CA USA
关键词
Bronchodilator; Inertial impaction parameter; Inhalation; Total Lung Dose (TLD); METERED-DOSE INHALER; OPTIMAL PARTICLE-SIZE; TERBUTALINE SULFATE; RESPIRATORY-TRACT; CYSTIC-FIBROSIS; INHALATION FLOW; AIR-FLOW; DEPOSITION; TURBUHALER(R); CHILDREN;
D O I
10.1007/s11095-016-2050-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Current marketed dry powder inhalers utilize the energy from patient inspiration to fluidize and disperse bulk powder agglomerates into respirable particles. Variations in patient inspiratory flow profiles can lead to marked differences in total lung dose (TLD), and ultimately patient outcomes for an inhaled therapeutic. The present review aims to quantitate the flow rate dependence in TLD observed for a number of drug/device combinations using a new metric termed the Q index. With this data in hand, the review explores key attributes in the design of the formulation and device that impact flow rate dependence. The review also proposes alternative in vitro methods to assess flow rate dependence that more closely align with in vivo observations. Finally, the impact of variations in flow rate on lung function for inhaled bronchodilators is summarized.
引用
收藏
页码:507 / 528
页数:22
相关论文
共 50 条
  • [1] The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers
    Jeffry Weers
    Andy Clark
    Pharmaceutical Research, 2017, 34 : 507 - 528
  • [2] Drug delivery to the lungs from dry powder inhalers
    Newman, SP
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 : S17 - S20
  • [3] Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers
    Broeders, MEAC
    Molema, J
    Vermue, NA
    Folgering, HTM
    EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (05) : 780 - 783
  • [4] Pressure and inspiratory flow characteristics of dry powder inhalers
    Cegla, UH
    RESPIRATORY MEDICINE, 2004, 98 : S22 - S28
  • [5] Is the Patient's Peak Inspiratory Flow Rate Important in the Prescription of Dry Powder Inhalers?
    O'Toole, P.
    Martin, R.
    Bernathpriya, Magimairaj
    McDonnell, T. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S284 - S284
  • [6] Dry powder inhalers for optimal drug delivery
    Newman, SP
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (01) : 23 - 33
  • [7] Impact of selected construction elements of capsule-based dry powder inhalers on the manner of drug delivery to the lungs
    Odziomek, Marcin
    Sosnowski, Tomasz R.
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2016, 12 (04): : 466 - 470
  • [8] Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers
    Ghosh, Sohini
    Ohar, Jill A.
    Drummond, M. Bradley
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (06) : 381 - 387
  • [9] Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers
    Chavan V.
    Dalby R.
    AAPS PharmSci, 2 (2): : 1 - 7
  • [10] Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers
    Chavan, V
    Dalby, R
    AAPS PHARMSCI, 2000, 2 (02):